Development of a PET-MR Myocardial Perfusion Examination Using Regadenoson (PET/MR-P)
This study has been completed.
Washington University School of Medicine
First Posted: January 30, 2013
Last Update Posted: May 12, 2017
Astellas Pharma US, Inc.
Information provided by (Responsible Party):
Pamela Woodard, MD, Washington University School of Medicine
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||June 2015|
|Primary Completion Date:||June 2015 (Final data collection date for primary outcome measure)|